Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Hint1 is a haplo-insufficient tumor suppressor in mice

Abstract

The HINT1 protein, a member of the histidine triad (HIT) family, is highly conserved in diverse species and ubiquitously expressed in mammalian tissues. However, its precise function in mammalian cells is not known. As a result of its structural similarity to the tumor-suppressor protein FHIT, we used homozygous-deleted Hint1 mice to study its role in tumorigenesis. We discovered that after 2 to 3 years of age the spontaneous tumor incidence in Hint1 −/− mice was significantly greater than that in wild-type Hint1 +/+ mice (P<0.05). Using a well-established mouse model of 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary carcinogenesis we found a marked and significant (P<0.05) increase in the incidence of mammary and ovarian tumors in both, Hint1 −/− and +/− mice versus +/+ mice. The Hint1 −/− and +/− mice had similar tumor incidence and similar tumor histologies. Therefore, deletion of Hint1 in mice enhances both spontaneous tumor development and susceptibility to tumor induction by DMBA. In addition, since the Hint1 +/− tumors retained expression of the unmutated wild-type allele, Hint1 is haplo-insufficient with respect to tumor suppression in this model system.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Aldaz CM, Liao QY, LaBate M, Johnston DA . (1996). Carcinogenesis 17: 2069–2072.

  • Archuleta MM, Born JL, Montano RM, Burchiel SW . (1992). Toxicol Appl Pharmacol 113: 133–137.

  • Barnes LD, Garrison PN, Siprashvili Z, Guranowski A, Robinson AK, Ingram SW et al. (1996). Biochemistry 35: 11529–11535.

  • Bieganowski P, Garrison PN, Hodawadekar SC, Faye G, Barnes LD, Brenner C . (2002). J Biol Chem 277: 10852–10860.

  • Brenner C . (2002). Biochemistry 41: 9003–9014.

  • Brenner C, Garrison P, Gilmour J, Peisach D, Ringe D, Petsko GA et al. (1997). Nat Struct Biol 4: 231–238.

  • Brzoska PM, Chen H, Levin NA, Kuo WL, Collins C, Fu KK et al. (1996). Genomics 36: 151–156.

  • Brzoska PM, Chen H, Zhu Y, Levin NA, Disatnik MH, Mochly-Rosen D et al. (1995). Proc Natl Acad Sci USA 92: 7824–7828.

  • Buters J, Quintanilla-Martinez L, Schober W, Soballa VJ, Hintermair J, Wolff T et al. (2003). Carcinogenesis 24: 327–334.

  • Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ et al. (2000). Oncogene 19: 968–988.

  • Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ . (1998). Nature 396: 177–180.

  • Fong LY, Fidanza V, Zanesi N, Lock LF, Siracusa LD, Mancini R et al. (2000). Proc Natl Acad Sci USA 97: 4742–4747.

  • Gilmour J, Liang N, Lowenstein JM . (1997). Biochem J 326: 471–477.

  • Goerlich O, Foeckler R, Holler E . (1982). Eur J Biochem 126: 135–142.

  • Guranowski A . (2004). Front Biosci 9: 1398–1411.

  • Guranowski A, Starzynska E, Taylor GE, Blackburn GM . (1989). Biochem J 262: 241–244.

  • Huebner K, Garrison PN, Barnes LD, Croce CM . (1998). Annu Rev Genet 32: 7–31.

  • Ingvarsson S . (2001). Semin Cancer Biol 11: 361–366.

  • Inoue K, Zindy F, Randle DH, Rehg JE, Sherr CJ . (2001). Genes Dev 15: 2934–2939.

  • Jackson RJ, Engelman RW, Coppola D, Cantor AB, Wharton W, Pledger WJ . (2003). Cancer Res 63: 3021–3025.

  • Kisselev LL, Justesen J, Wolfson AD, Frolova LY . (1998). FEBS Lett 427: 157–163.

  • Klein MG, Yao Y, Slosberg ED, Lima CD, Doki Y, Weinstein IB . (1998). Exp Cell Res 244: 26–32.

  • Knudson Jr AG . (1971). Proc Natl Acad Sci USA 68: 820–823.

  • Korsisaari N, Makela TP . (2000). J Biol Chem 275: 34837–34840.

  • Korsisaari N, Rossi DJ, Luukko K, Huebner K, Henkemeyer M, Makela TP . (2003). Mol Cell Biol 23: 3929–3935.

  • Lee YN, Nechushtan H, Figov N, Razin E . (2004). Immunity 20: 145–151.

  • Lima CD, Klein MG, Hendrickson WA . (1997). Science 278: 286–290.

  • Lima CD, Klein MG, Weinstein IB, Hendrickson WA . (1996). Proc Natl Acad Sci USA 93: 5357–5362.

  • Malkinson AM, Thaete LG . (1986). Cancer Res 46: 1694–1697.

  • Medina D, Butel JS, Socher SH, Miller FL . (1980). Cancer Res 40: 368–373.

  • Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J et al. (1996). Cell 84: 587–597.

  • Pierce Jr DF, Gorska AE, Chytil A, Meise KS, Page DL, Coffey Jr RJ et al. (1995). Proc Natl Acad Sci USA 92: 4254–4258.

  • Qing WG, Conti CJ, LaBate M, Johnston D, Slaga TJ, MacLeod MC . (1997). Carcinogenesis 18: 553–559.

  • Quon KC, Berns A . (2001). Genes Dev 15: 2917–2921.

  • Razin E, Zhang ZC, Nechushtan H, Frenkel S, Lee YN, Arudchandran R et al. (1999). J Biol Chem 274: 34272–34276.

  • Seraphin B . (1992). DNA Seq 3: 177–179.

  • Su T, Suzui M, Wang L, Lin CS, Xing WQ, Weinstein IB . (2003). Proc Natl Acad Sci USA 100: 7824–7829.

  • Threadgill DW, Yee D, Matin A, Nadeau JH, Magnuson T . (1997). Mamm Genome 8: 390–393.

  • Vartanian A, Alexandrov I, Prudowski I, McLennan A, Kisselev L . (1999). FEBS Lett 456: 175–180.

  • Venkatachalam S, Shi YP, Jones SN, Vogel H, Bradley A, Pinkel D et al. (1998). Embo J 17: 4657–4667.

  • Witty JP, Lempka T, Coffey Jr RJ, Matrisian LM . (1995). Cancer Res 55: 1401–1406.

  • Yao Y, Slosberg ED, Wang L, Hibshoosh H, Zhang YJ, Xing WQ et al. (1999). Oncogene 18: 5159–5166.

  • Yuan BZ, Jefferson AM, Popescu NC, Reynolds SH . (2004). Neoplasia 6: 412–419.

  • Zanesi N, Fidanza V, Fong LY, Mancini R, Druck T, Valtieri M et al. (2001). Proc Natl Acad Sci USA 98: 10250–10255.

Download references

Acknowledgements

We thank MM Mansukhani and H Hibshoosh, Department of Pathology, Columbia University, for valuable advice on the histological studies, and CW Rumsey and A Herron, Institute of Comparative Medicine, Columbia University, for histopathological verification. We are also grateful to members of the Weinstein laboratory for critical comments on the manuscript. This research was supported by National Cancer Institute Grant CA26056-24, the TJ Martell Foundation, and the National Foundation for Cancer Research (to IB Weinstein), and National Cancer Institute Grants ES05116 and P30ES09089 (to RM Santella).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I B Weinstein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, H., Zhang, Y., Su, T. et al. Hint1 is a haplo-insufficient tumor suppressor in mice. Oncogene 25, 713–721 (2006). https://doi.org/10.1038/sj.onc.1209111

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209111

Keywords

This article is cited by

Search

Quick links